Previous 10 | Next 10 |
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that Unite...
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pl...
MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a health...
MALVERN, Pa., April 06, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced improved interne...
2023-04-04 10:58:44 ET Neuronetics ( NASDAQ: STIM ) said it had entered a new credit facility with SLR Capital Partners, which will provide borrowings of up to $60M in three tranches of term loans. The maturity date of the facility is March 29, 2028. The Company ...
MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, today provided a co...
MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Li...
2023-03-07 10:18:02 ET Neuronetics, Inc. (STIM) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Company Participants Mark Klausner - ICR Westwicke Keith Sullivan - President and Chief Executive Officer Steve Furlong - Chief Financial Officer Confe...
2023-03-07 10:07:46 ET The following slide deck was published by Neuronetics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Neuronetics, Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-07 07:32:36 ET Neuronetics press release ( NASDAQ: STIM ): Q4 GAAP EPS of -$0.30 beats by $0.08 . Revenue of $18.2M (+21.2% Y/Y) beats by $0.2M . Outlook: For the first quarter of 2023, the Company expects total worldwide revenue between $15.0 milli...
News, Short Squeeze, Breakout and More Instantly...
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that Aetna has updated its TMS (tr...
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that California Medicaid (Medi-Cal...